top of page

Initial Frequency Assesment


Discover what may be disrupting your body's balance and where to begin.

2 hr - 2 hr 30 min
From 297 US dollars
Naples|Fort Lauderdale

Service Description

Your wellness journey begins with clarity. During your initial assessment, we use frequency-based scanning to explore patterns of imbalance and identify areas that may be placing stress on your system. We’ll explore your goals, symptoms, lifestyle, and frequency patterns to build a clearer picture of where your system may need support. From there, we begin a personalized frequency-based session focused on the areas your system is showing as the highest priority for support. We close the session by supporting regulation and integration, helping your system settle and respond to the frequency work. Essential — $297 | 2 hours Includes your complete frequency assessment followed by a focused frequency therapy session. Comprehensive — $377 | 2.5 hours Includes the same complete frequency assessment, with additional time dedicated to frequency therapy based on your individual priorities.


Contact Details

  • 365 5th Avenue South, Naples, FL, USA

    917-535-1985

    info@resowave.com

  • The Biohack Lab, 1785 Southeast 17th Street, Fort Lauderdale, FL, USA

    917-535-1985

    info@resowave.com


  • Instagram

Disclamer

Disclaimer: Although the technology behind the biofield device has been evolving for over 40 years, its connection to health and wellness has not been established or demonstrated to the extent required by the Federal Drug Administration (FDA) for medical devices. Operation of the biofield device should not be intended or construed to diagnose, cure, mitigate, prevent or treat any disease or medical condition but rather, along with a healthy diet and lifestyle, to support and promote energetic balance and enhance healthy function, vitality and wellbeing. The biofield device has been designed and constructed with the intention to meet the non-binding recommendations set forth in docket number FDA-2014-N-1039: “General Wellness, Policy for low-risk devices; Guidance for Industry and Food and Drug Administration Staff” issued September 27, 2019 

bottom of page